Rangering i aksjer
#30765
Lobe Sciences Ltd. operates as a life sciences entity, primarily focused on the... Lobe Sciences Ltd. operates as a life sciences entity, primarily focused on the exploration and advancement of psychedelic pharmaceutical compounds. The company is actively engaged in formulating psilocybin-derived therapeutics, combined with N-acetylcysteine, intended for the treatment of mild traumatic brain injuries and post-traumatic stress disorder. Beyond drug development, it also engineers specialized devices designed to facilitate the efficient delivery of various medications. The organization was previously known as Greenstar Biosciences Corp. before formally changing its name to Lobe Sciences Ltd. in November 2020. Its main corporate office is situated in Vancouver, Canada.
Aksjekurs
$0.05504527
Sist synkronisert: 2026-08-17
Handel Lobe Sciences Ltd. (LOBE)
Pris LOBE pris med markedsverdi på B
Markedsverdi av Lobe Sciences Ltd.(LOBE)
Markedsverdi: $15.64M
Per August 2026 har Lobe Sciences Ltd. en markedsverdi på $15.64M. Dette gjør Lobe Sciences Ltd. til det 30765th mest verdifulle selskapet i verden basert på markedsverdi ifølge våre data. Markedsverdi er den totale markedsverdien av et børsnotert selskaps utestående aksjer og brukes vanligvis til å måle hvor mye et selskap er verdt.
Markedsverdihistorikk for Lobe Sciences Ltd. fra 2012 til 2026
LOBE sammenlignet med topp 5 mest populære stocks
| Pris på LOBE |
|
Eiendel B |
Markedsverdi for B |
Resultater |
|
|
|
|
$5.307T
|
+33,932,629.75%
|
|
|
|
|
$4.551T
|
+29,099,383.87%
|
|
|
|
|
$4.154T
|
+26,564,821.13%
|
|
|
|
|
$3.589T
|
+22,946,727.11%
|
|
|
|
|
$2.797T
|
+17,884,232.45%
|
